|
|
Office Locations:
|
8025 Forsyth Blvd., Second Floor
St. Louis, MO 63105
Phone: 314-448-1316
Fax: 314-335-7637
| | |
|
|
|
|
|
Financial Services
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
Medical Device
|
|
|
|
Augury Capital Partners is an emerging technologies private equity fund with investments in mid-stage or later companies. Augury Capital has developed an investment profile in privately held pharmaceutical, biotechnology, medical device and financial service informational technology companies. Specific target opportunities Mid and Late-stage Medical Device companies (lower regulatory hurdle and quicker path to revenues) and medical device service companies; Mid and Late-stage Service/Tool companies with unique technologies and/or services that solve fundamental issues (usually no regulatory hurdle with short-term revenue path); Late-stage Biopharmaceutical companies; Mid and Late-stage financial services information technologies companies, particularly companies in the transaction processing sector; Revenue generating companies with positive cash flow or expected cash flow within 12 months; and Companies seeking expansion capital.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
